RE:RE:Td Our C$2.75 target price (down from C$3.00) > Dead money IMO until end of year?
I don't think so. They should start having very favorable YoY comparables beginning with the Q2 financials. And if we start seeing material ramp up in the Syline/ECN partnership by then, we should see this stock being re-rated. But share price could be weak for another five months here.
It would be nice if Mr. Hudson start making those big insider buys in the open market again. Could be a sign ECN is indeed recovering in 2024 and help the share price.